Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Elyn tells you about papers on blood biomarkers for AD in this episode of AMiNDR! This includes a range of topics, including RNA biomarkers, neurofilament light, proteins biomarkers, and more! All of the papers are from June, 2020. Enjoy the episode and keep your eye out for more biomarker episodes coming very soon!

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

In part 2, Bhumika tells you all about the new papers on imaging tools for AD from June 2020! You'll hear more about studies on using imaging technology such as MRI and PET to diagnose AD. If this is a topic that interests you, check out part 1 as well!

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Sarah has a lot of fun hosting this highly interesting episode covering papers published in June 2020 on amyloid-beta-mediated toxicity in AD! We hope you enjoy, and that this update is useful for your research! If you're interested in papers on other mechanisms of amyloid-beta pathology in AD, check out episode #13 on APP processing and amyloid-beta aggregation.

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Bhumika tells you all about the new papers on imaging tools for AD from June 2020! You'll hear about tools for the prediction of disease progression, the classification of AD, and the initial diagnosis of AD. New machine learning and bioinformatics tools for AD research and diagnosis are also covered in this episode. This is only part 1, stay tuned for part 2, coming out soon!

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Joseph tells you about more papers on drugs in development from June 2020. These studies encompass those done in vitro or using computational models, but not animal testing. This episode brings together abstracts that were not sorted into a specific target cluster, so you will hear about a variety of treatment targets such as histone deacetylase, caspase-6, monoamine oxidase, microRNA, and more!

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

In this episode, Sarah updates you on the papers from June 2020 that aim to refine or repurpose drugs and other treatments for Alzheimer's disease! This includes studies on refining existing AD treatments, refining the method of delivery, and repurposing non-AD drugs for use in AD treatment. If you're interested in learning more about research on AD treatments, you should also check out our episodes on novel drug development, pre-clinical and clinical testing. Enjoy today's episode!

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Joseph tells you about more papers on drugs in development from June 2020. These studies encompass those done in vitro or using computational models, but not animal testing. Here, you will hear about approaches with multiple targets: cholinesterase, amyloid-beta, tau, oxidative stress... If you're interested in hearing more about treatments for AD, you should also check out our episodes on pre-clinical and clinical testing.

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Ellen tells you about more papers on drugs in development from June 2020. These studies encompass those done in vitro or using computational models, but not animal testing. This time around, she will be focusing on papers where the target is tau protein, the cholinergic system, metabolism, mitochondria, neuroinflammation, and autophagy from June 2020! If you're interested in hearing more about treatments for AD, you should also check out our episodes on pre-clinical and clinical testing.

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

Ellen tells you about papers on drugs in development targeting amyloid-beta production, aggregation, and toxicity from June 2020! If you're interested in hearing more about treatments for AD, you should also check out our episodes on pre-clinical and clinical testing.

Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!

In this episode, Marcia covers papers published in June 2020 on treatment development done on animal models, targeting metabolism, mitochondria, oxidative stress, the gut microbiome, inflammatory pathways, glia, and autophagy. If you are interested in learning more about these pathological events, you should check out our episode on these disease mechanisms, covered by Anusha. We also have a number of episodes dedicated to pre-clinical testing, split by the intended target the cholinergic system, the glutamatergic system, synaptic function, tau, amyloid-beta, cognitive performance, and other multitargeted approaches.

Enjoy!